Biohaven Ltd’s filing revealed that its Director Bailey Gregory acquired Company’s shares for reported $1.0 million on Apr 24 ’24. In the deal valued at $39.18 per share,25,503 shares were bought. As a result of this transaction, Bailey Gregory now holds 1,600,071 shares worth roughly $65.11 million.
Then, CHILDS JOHN W bought 195,121 shares, generating $7,999,961 in total proceeds. Upon buying the shares at $41.00, the Director now owns 4,096,512 shares.
Before that, Coric Vlad bought 121,951 shares. Biohaven Ltd shares valued at $4,999,991 were divested by the Chief Executive Officer at a price of $41.00 per share. As a result of the transaction, Coric Vlad now holds 1,788,417 shares, worth roughly $72.77 million.
RBC Capital Mkts initiated its Biohaven Ltd [BHVN] rating to an Outperform in a research note published on February 16, 2024; the price target was $62. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. H.C. Wainwright began covering BHVN with “Buy” recommendation on December 22, 2023. Robert W. Baird started covering the stock on December 08, 2023. It rated BHVN as “an Outperform”.
Price Performance Review of BHVN
On Friday, Biohaven Ltd [NYSE:BHVN] saw its stock jump 1.98% to $40.69. Over the last five days, the stock has gained 4.41%. Biohaven Ltd shares have fallen nearly -4.93% since the year began. Nevertheless, the stocks have risen 195.93% over the past one year. While a 52-week high of $62.21 was reached on 03/08/24, a 52-week low of $13.03 was recorded on 04/25/24. SMA at 50 days reached $49.98, while 200 days put it at $35.63. A total of 0.78 million shares were traded, compared to the trading of 0.8 million shares in the previous session.
Levels Of Support And Resistance For BHVN Stock
The 24-hour chart illustrates a support level at 40.06, which if violated will result in even more drops to 39.43. On the upside, there is a resistance level at 41.71. A further resistance level may holdings at 42.74. The Relative Strength Index (RSI) on the 14-day chart is 38.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.61%. Stochastics %K at 28.14% indicates the stock is a holding.
The most recent change occurred on January 24, 2023 when SVB Securities began covering the stock and recommended ‘”an Outperform”‘ rating along with a $24 price target.
